These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24833688)

  • 21. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease.
    Rees K; Takeda A; Martin N; Ellis L; Wijesekara D; Vepa A; Das A; Hartley L; Stranges S
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009825. PubMed ID: 30864165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of cardiovascular disease risk factors, assessment and management in men and women, including consideration of absolute risk: a nationally representative cross-sectional study.
    Banks E; Welsh J; Joshy G; Martin M; Paige E; Korda RJ
    BMJ Open; 2020 Dec; 10(12):e038761. PubMed ID: 33371018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. General practitioners' perspectives on the prevention of cardiovascular disease: systematic review and thematic synthesis of qualitative studies.
    Ju I; Banks E; Calabria B; Ju A; Agostino J; Korda RJ; Usherwood T; Manera K; Hanson CS; Craig JC; Tong A
    BMJ Open; 2018 Nov; 8(11):e021137. PubMed ID: 30389756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management outcomes of patients with type 2 diabetes: targeting the 10-year absolute risk of coronary heart disease.
    Yong TY; Phillipov G; Phillips PJ
    Med J Aust; 2007 Jun; 186(12):622-4. PubMed ID: 17576176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Fremantle Primary Prevention Study: a multicentre randomised trial of absolute cardiovascular risk reduction.
    Brett T; Arnold-Reed D; Phan C; Cadden F; Walker W; Manea-Walley W; Mora N; Young J; Bulsara M
    Br J Gen Pract; 2012 Jan; 62(594):e22-8. PubMed ID: 22520669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
    Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
    BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omega-6 fats for the primary and secondary prevention of cardiovascular disease.
    Hooper L; Al-Khudairy L; Abdelhamid AS; Rees K; Brainard JS; Brown TJ; Ajabnoor SM; O'Brien AT; Winstanley LE; Donaldson DH; Song F; Deane KH
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011094. PubMed ID: 30488422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omega-6 fats for the primary and secondary prevention of cardiovascular disease.
    Hooper L; Al-Khudairy L; Abdelhamid AS; Rees K; Brainard JS; Brown TJ; Ajabnoor SM; O'Brien AT; Winstanley LE; Donaldson DH; Song F; Deane KH
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011094. PubMed ID: 30019765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Web-based self-assessment health tools: who are the users and what is the impact of missing input information?
    Neufingerl N; Cobain MR; Newson RS
    J Med Internet Res; 2014 Sep; 16(9):e215. PubMed ID: 25261155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary fibre for the primary prevention of cardiovascular disease.
    Hartley L; May MD; Loveman E; Colquitt JL; Rees K
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011472. PubMed ID: 26758499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?
    van Peet PG; Gussekloo J; den Elzen WP; Blom JW; de Waal MW; de Ruijter W
    Scand J Prim Health Care; 2015; 33(4):260-8. PubMed ID: 26683286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-sectional survey describing general practitioners' absolute cardiovascular disease risk assessment practices and their relationship to knowledge, attitudes and beliefs about cardiovascular disease risk in Queensland, Australia.
    Greaves K; Smith A; Agostino J; Kunarajah K; Stanton T; Korda R
    BMJ Open; 2020 Aug; 10(8):e033859. PubMed ID: 32792422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dyslipidaemia in rural Australia: prevalence, awareness, and adherence to treatment guidelines in the Greater Green Triangle Risk Factor Study.
    Janus ED; Tideman PA; Dunbar JA; Kilkkinen A; Bunker SJ; Philpot B; Tirimacco R; Mc Namara K; Heistaro S; Laatikainen T
    Med J Aust; 2010 Feb; 192(3):127-32. PubMed ID: 20121678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.
    Kones R
    Vasc Health Risk Manag; 2013; 9():617-70. PubMed ID: 24174878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of blood pressure-lowering drug treatment by levels of absolute risk: post hoc analysis of the Australian National Blood Pressure Study.
    Ho CLB; Breslin M; Doust J; Reid CM; Nelson MR
    BMJ Open; 2018 Mar; 8(3):e017723. PubMed ID: 29555790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk.
    Patel A; Cass A; Peiris D; Usherwood T; Brown A; Jan S; Neal B; Hillis GS; Rafter N; Tonkin A; Webster R; Billot L; Bompoint S; Burch C; Burke H; Hayman N; Molanus B; Reid CM; Shiel L; Togni S; Rodgers A;
    Eur J Prev Cardiol; 2015 Jul; 22(7):920-30. PubMed ID: 24676715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tai chi for primary prevention of cardiovascular disease.
    Hartley L; Flowers N; Lee MS; Ernst E; Rees K
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010366. PubMed ID: 24715694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient Characteristics and General Practitioners' Advice to Stop Statins in Oldest-Old Patients: a Survey Study Across 30 Countries.
    van der Ploeg MA; Streit S; Achterberg WP; Beers E; Bohnen AM; Burman RA; Collins C; Franco FG; Gerasimovska-Kitanovska B; Gintere S; Gomez Bravo R; Hoffmann K; Iftode C; Peštić SK; Koskela TH; Kurpas D; Maisonneuve H; Mallen CD; Merlo C; Mueller Y; Muth C; Petrazzuoli F; Rodondi N; Rosemann T; Sattler M; Schermer T; Šter MP; Švadlenková Z; Tatsioni A; Thulesius H; Tkachenko V; Torzsa P; Tsopra R; Tuz C; Vaes B; Viegas RPA; Vinker S; Wallis KA; Zeller A; Gussekloo J; Poortvliet RKE
    J Gen Intern Med; 2019 Sep; 34(9):1751-1757. PubMed ID: 30652277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.
    Flowers N; Hartley L; Todkill D; Stranges S; Rees K
    Cochrane Database Syst Rev; 2014; 2014(12):CD010405. PubMed ID: 25474484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.